Key result
Greater cardiometabolic multimorbidity in STEMI is linked to worse LV function without altering infarct size.
Why the study?
Does increasing cardio-renal-metabolic multimorbidity burden associate with greater infarct extent or worse myocardial structural and functional parameters in first-time acute STEMI patients?
Cohort (n=782)
Does increasing cardio-renal-metabolic multimorbidity burden associate with greater infarct extent or worse myocardial structural and functional parameters in first-time acute STEMI patients?
In acute STEMI patients, cardio-renal-metabolic multimorbidity drives a distinct phenotype of diastolic dysfunction, impaired longitudinal mechanics, reduced myocardial work efficiency, and lower cardiac index independent of infarct size.
Answers are grounded in this paper and cite their sources.
CRM multimorbidity may warrant closer functional monitoring in STEMI beyond infarct size; leaves open whether targeted interventions improve outcomes.
Background Cardio-renal-metabolic (CRM) multimorbidity, encompassing hypertension, diabetes mellitus, and chronic kidney disease, is highly prevalent in patients presenting with ST-elevation myocardial infarction (STEMI). While CRM is associated with adverse cardiovascular outcomes, its relationship with infarct extent versus myocardial structural and functional profile in acute STEMI remains insufficiently defined. Objective To determine whether CRM burden is associated with infarct extent or defines a distinct myocardial structural–functional phenotype using integrated echocardiography and CMR in contemporary STEMI cohort. Methods This prospective study included 782 first-time STEMI patients treated with primary. CRM burden was defined as the coexistence of hypertension, diabetes mellitus, and chronic kidney disease and categorized as 0, 1, 2, or 3 conditions according to established clinical criteria. Early advenced echocardiography was performed in all patients and discharge CMR in 249 patients. Group comparisons were assessed using ANOVA. Results Infarct characteristics did not differ across CRM groups, including infarct size (14.0±10.6% vs 16.9±11.3% vs 15.5±9.1% vs 12.5±10.1%; p=0.278), MVO (p=0.623), and IMH segments (p=0.357). In contrast, increasing CRM burden was associated with a graded deterioration in myocardial structural and functional parameters. E/E′ rose from 8.95±2.59 to 12.71±4.40 (p<0.001), septal E′ decreased from 6.14±1.95 to 4.14±1.14 cm/s (p<0.001), and GLS worsened from −14.0±4.1% to −11.1±3.7% (p=0.001). Global wasted work increased (203.7±191 to 393.4±663 mmHg%, p<0.001), while global work efficiency declined (86.6±8.2% to 80.4±10.6%, p<0.001). Left atrial volume index increased (27.2±7.1 vs 35.5±12.4 mL/m²; p<0.001) with concomitant reduction in atrial strain (p<0.001). In the CMR subgroup, infarct extent remained similar across CRM strata; however, cardiac index declined from 2.75±0.69 to 2.10±0.50 L/min/m² (p<0.001), with a parallel reduction in RV cardiac index (2.55±0.67 to 2.08±0.43 L/min/m²; p<0.001). Conclusion In acute STEMI, cardio-renal-metabolic multimorbidity is not associated with greater infarct size or reperfusion injury. However, increasing CRM burden defines a distinct myocardial structural and functional phenotype characterized by concentric remodeling, diastolic dysfunction, impaired longitudinal mechanics, reduced myocardial work efficiency, and diminished forward flow. These findings indicate that CRM burden identifies a distinct cardiac structural–functional phenotype independent of infarct extent.
No takes yet. Share an insight, caveat, or question.
Stanković et al. (2026) conducted a cohort in Acute ST-elevation myocardial infarction (STEMI) (n=782). Cardio-renal-metabolic (CRM) multimorbidity (1, 2, or 3 conditions: hypertension, diabetes mellitus, chronic kidney disease) vs. 0 CRM conditions was evaluated on Infarct size and myocardial structural and functional parameters (e.g., E/E′, GLS, global work efficiency, cardiac index) (p=0.278). Increasing CRM burden in STEMI did not affect infarct size but worsened E/E′, GLS, and cardiac index.
Synapse has enriched 10 related papers. Consider them for comparative context: